Back to Search
Start Over
IL-1β, IL-10 and TNF-α polymorphisms may affect systemic lupus erythematosus risk and phenotype.
- Source :
-
Clinical and experimental rheumatology [Clin Exp Rheumatol] 2022 Sep; Vol. 40 (9), pp. 1708-1717. Date of Electronic Publication: 2022 Jan 05. - Publication Year :
- 2022
-
Abstract
- Objectives: Systemic lupus erythematosus (SLE) is an autoimmune disease, and IL-1β, IL-10, and TNF-α genes are important in the pathogenesis of this disease. We studied the impact of IL-1β-511, IL-1β +3953, IL-10 -592, IL-10 -1082, TNF-α -308, TNF-α -238, and TNF-α +489 polymorphisms on SLE risk and phenotype in SLE patients and healthy controls.<br />Methods: We genotyped SLE patients and healthy controls by real-time PCR on QuantStudio 5 (Applied Biosystems) and measured levels of cytokines by enzyme-linked immunosorbent assay (ELISA).<br />Results: We indicated that TNF-α -308, IL-10 -592, IL-10 -1082, IL-1β-511 and IL-1β +3953 polymorphisms affect SLE risk. Furthermore, we exposed that some of the TNF-α +489, TNF-α -238, IL-10 -1082 and IL-1β +3953 genotypes are connected with the SLE phenotype. Moreover, we discovered the linking between specific genotypes and the serum concentrations of TNF-α, IL-1β, and IL-10.<br />Conclusions: In conclusion, our study revealed that IL-1β-511, IL-1β +3953, IL-10 -592, IL-10 -1082, and TNF-α -308 polymorphisms may affect SLE risk and phenotype.
- Subjects :
- Cytokines
Genotype
Humans
Phenotype
Polymorphism, Genetic
Interleukin-10 blood
Interleukin-10 genetics
Interleukin-1beta blood
Interleukin-1beta genetics
Lupus Erythematosus, Systemic blood
Lupus Erythematosus, Systemic diagnosis
Lupus Erythematosus, Systemic genetics
Tumor Necrosis Factor-alpha blood
Tumor Necrosis Factor-alpha genetics
Subjects
Details
- Language :
- English
- ISSN :
- 0392-856X
- Volume :
- 40
- Issue :
- 9
- Database :
- MEDLINE
- Journal :
- Clinical and experimental rheumatology
- Publication Type :
- Academic Journal
- Accession number :
- 35084314
- Full Text :
- https://doi.org/10.55563/clinexprheumatol/qdgq0v